| Tag | Content |
|---|
EnhancerAtlas ID | HS154-09807 |
Organism | Homo sapiens |
Tissue/cell | Osteoblast |
Coordinate | chr17:66308080-66309900 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| JUN | MA0488.1 | chr17:66309681-66309694 | ATGACCTCATCTT | - | 6.54 | | JUND(var.2) | MA0492.1 | chr17:66309680-66309695 | TATGACCTCATCTTA | - | 7.07 | | SPI1 | MA0080.4 | chr17:66308570-66308584 | AACTTCCGCTTTCA | - | 6.3 | | SPIB | MA0081.2 | chr17:66308570-66308582 | AACTTCCGCTTT | - | 6.22 | | Zfx | MA0146.2 | chr17:66309162-66309176 | GAGGCCGAGGCGGG | - | 6.01 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09251 | chr17:66305869-66313289 | CD14 | | SE_34520 | chr17:66308079-66309665 | HCT-116 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I068311 | chr17 | 66307639 | 66311781 |
|
Enhancer Sequence | ACAAGCATCT GCTGCCATGC CTGGCTAATT TTTGTATTTT TGTAGAGATG GGGTTTCACC 60
ATGTTGGCTA GGCTACTCTC GAACCCCTGA CCTCAAGTGA TCCACTCGCC TTGGCCTCCC 120
AAAGTGCTGC GATTACAGGT CTGAGCCACC ACGCCTGGCC TGTACTGTTG TTTTAAGCCA 180
CACAGCTTGT GGTAATTTGT TATGGCAGCC ACAGAAAACT TACACACCTC CCTCCTAGCT 240
CTGGACTTCA GGAAGAAAAA TGCCTCATCT GTTCTTTCCC GCTTATATTC CTAGCATGTA 300
ACACAGTGCT TGGTACGTAG TGGGCAATTA ATAAATATTT GTTCATCAAT AAATGGGCTC 360
TAGGAGCTCA AGATGCCCTG GAATGTCACC CCAAATTTTG CATGTAGGAA TACTTTTCTG 420
GGGAGAGAGT TCATCCATTC ATGAACATTT ACCAGATTCT CCAAAGGGCG TGGGTTGCCA 480
AATGCTTAGG AACTTCCGCT TTCAGTGTTT AGCAGGTTAG CGGGGAAATA TTAGTCCCAT 540
TATTTAAGCT GAGATTTGCG AGGCCTACAC GTTTTTTTTT TCTCATGTGC TGTCTCTACT 600
GTCACACTCT CATCCTGAGC AGAAAGGAGG ACTCAGGGGT CAGATGCCAA ATGTGGTTCG 660
TTGGGCTCTC CTTCTCCCCA CCCCCTTATG AAAGTGTTTC TTTCCATCTG AGCCTTGTGA 720
CAGTGGCCAG GTGGCTAGCC CTCTGGCCTG AGGTCGACGG CTTTTCATTC TTCTTTGTTG 780
ACAGGAAAGC CGGGCTTCCT GTGAGGCCAT GAACTGATTC ATCGCTGGTT TCTCCCACTG 840
CCTACTCACG GCCAGTGGGG AACCATGACT TTCAGACACG AACTCTTATT GCCCAACAGG 900
GTCTGGGGTG ACTAGCTGGG ACTGCACGCT CAAGCCACCA CGCCCGGTTC TGTTGCCTCC 960
TTTTTATTTG TGCATGAATT TTCTAGGACT GCTGGAACAA ATTACTCCAA ACTGGACAGC 1020
TTAAAATGTT ACTTTGTTCT GGCCAGGCAC AGTGGCTCAC ACCTGTAATC CCAGCACTTT 1080
GGGAGGCCGA GGCGGGCAGA TCACGAGGTC AGGAGATCAA GACCATCCTG GCTAACGTGG 1140
TGAAACGCTG TCACTACTAA AAATACAAAA AATTAGCCGG GCATGGTGGC AGGTGCCTGT 1200
AGTCCCAGCT ACTCAGGAGG CTGAGGCAGG AGAATGGCGT GAACCCGGGA GGCAGAGATT 1260
GCAGTGAGCC GAGATTGCGC CACTGCACTC CAGCCTGGGT GACAGAGTGA GACTCCATCT 1320
CAAAAAAAAC AAAAATAAAA ACAAAAAAAC ATTACTTTGT CCTTTCACAG TTCGGAGAGC 1380
CAGAAGTCCA AAATCAAGGT TATGACTGAA GGCTCTGACA GAGAATCCAT TCCTTGCCTC 1440
TCTCCTGGAT TCTGGTGCCT GCTGGAATCC TTGGCATTCT GGGCTTCTAG ACTCCTATCT 1500
CCGCCTCAGT TGTTATGAGG CGTTCTTTCA TGCCAGTGTC CAGACTCCCC TCCTCTAATA 1560
AAAATACCAG TCTTTGGATT GAAGGCCCAC CCTACTCCAG TATGACCTCA TCTTAACTTA 1620
ATGACATCTG CGAAGACGCT ATCTCCAAAT AAGGTCACGT CACAGGTTCT GGATTGATAT 1680
GAAATTGAGG GGAACGCTGT TCAGTCTGGT GCAATTAGCT GTATTACGTA TCTCTCTCTC 1740
TCTCTTTTTT TTTTTTTTGA GACACAGTTT CACTCTGTTG CCCAGGCTGG AGTGCAGTGG 1800
TGCAATCTTG GCTCACTGCA 1820
|
